Neoadjuvant Therapy: Current Landscape and Future Horizons for ER-Positive/HER2-Negative and Triple-Negative Early Breast Cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Neoadjuvant Therapy: Current Landscape and Future Horizons for ER-Positive/HER2-Negative and Triple-Negative Early Breast Cancer ; volume:25 ; number:9 ; day:15 ; month:8 ; year:2024 ; pages:1210-1224 ; date:9.2024
Current treatment options in oncology ; 25, Heft 9 (15.8.2024), 1210-1224, 9.2024
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Bischoff, Hervé
Espié, Marc
Petit, Thierry
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11864-024-01251-y
- URN
-
urn:nbn:de:101:1-2412050703220.084795554316
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bischoff, Hervé
- Espié, Marc
- Petit, Thierry
- SpringerLink (Online service)
Ähnliche Objekte (12)
Efficacy and prognosis of HER2-Low and HER2-Zero in triple-negative breast cancer after neoadjuvant chemotherapy
Evaluation of neoadjuvant chemotherapy for clinical T1 triple-negative breast cancer
De-escalation of Systemic Therapy for Early-Stage, Node-Negative Her2+ and Triple-Negative Breast Cancer
SABCS 2020: update on triple-negative and metastatic HER2-positive breast cancer
The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer
Escalation of neoadjuvant therapy in triple-negative breast cancer—balancing effectiveness and toxicities
Metastatic Triple-Negative Breast Cancer
The impact of HER2-low status on response to neoadjuvant chemotherapy in clinically HER2-negative breast cancer
HER2-low and tumor infiltrating lymphocytes in triple-negative breast cancer: Are they connected?
Triple-negative and HER2-positive breast cancers found by mammography screening show excellent prognosis
Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial
Efficacy and prognosis of HER2-Low and HER2-Zero in triple-negative breast cancer after neoadjuvant chemotherapy
Evaluation of neoadjuvant chemotherapy for clinical T1 triple-negative breast cancer
De-escalation of Systemic Therapy for Early-Stage, Node-Negative Her2+ and Triple-Negative Breast Cancer
SABCS 2020: update on triple-negative and metastatic HER2-positive breast cancer
The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer
Escalation of neoadjuvant therapy in triple-negative breast cancer—balancing effectiveness and toxicities
Metastatic Triple-Negative Breast Cancer
The impact of HER2-low status on response to neoadjuvant chemotherapy in clinically HER2-negative breast cancer
HER2-low and tumor infiltrating lymphocytes in triple-negative breast cancer: Are they connected?
Triple-negative and HER2-positive breast cancers found by mammography screening show excellent prognosis
Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial
Efficacy and prognosis of HER2-Low and HER2-Zero in triple-negative breast cancer after neoadjuvant chemotherapy
Evaluation of neoadjuvant chemotherapy for clinical T1 triple-negative breast cancer
De-escalation of Systemic Therapy for Early-Stage, Node-Negative Her2+ and Triple-Negative Breast Cancer
SABCS 2020: update on triple-negative and metastatic HER2-positive breast cancer
The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer
Escalation of neoadjuvant therapy in triple-negative breast cancer—balancing effectiveness and toxicities
Metastatic Triple-Negative Breast Cancer
The impact of HER2-low status on response to neoadjuvant chemotherapy in clinically HER2-negative breast cancer
HER2-low and tumor infiltrating lymphocytes in triple-negative breast cancer: Are they connected?
Triple-negative and HER2-positive breast cancers found by mammography screening show excellent prognosis